While at SCOPE 2025, Sam Srivastava, CEO at WCG Clinical discusses the challenges and responsibilities of the life sciences ...

Tech firm Clario is boosting its electronic clinical outcome assessment (eCOA) offerings by acquiring the ...

The eCOA business claims to provide clinical expertise, especially in the areas of psychiatry, neuropathic pain.

PHILADELPHIA, March 10, 2025 /PRNewswire/ -- Clario, a leading provider of endpoint data solutions to the clinical trial ...

Clario, a Philadelphia-based provider of endpoint data solutions to the clinical trial industry, has agreed to acquire WCG’s electronic clinical outcome assessments business. No financial terms were ...

So our competitors continue to be the likes of Signet Health and WCG Clinical, who are the largest competitors in our space. In terms of, I think the reference was made there to biomarkers and ...

Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neuroscience PHILADELPHIA, March 10, 2025 /PRNewswire ...

WCG's eCOA operations offer robust, full-service clinical expertise and specialized functionality, particularly in neurology, psychiatry, neuropathic pain, and rare diseases. "WCG's eCOA ...

PRINCETON, N.J., Feb. 18, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today unveiled IBC+, an innovative approach to ...